Buehlmann


Anti-MAG

The Expert's Choice for the “Gold Standard” FOR anti-MAG testing

test

Based on human Myelin, the anti-MAG ELISA from BÜHLMANN is the most sensitive and specific assay on the market. Mark Kuijf showed in a very recent study involving 68 paients that the anti-MAG ELISA was considerably more sensitive as compared to the Western Blot.
Not only is it possible to measure even very low anti-MAG antibody titers but also to follow titers in patients under new therapies such as Rituximab.

MAG is a constituent of peripheral and central nervous system myelin. High titers of IgM anti-MAG antibodies are associated with sensory motor demyelinating peripheral neuropathy. Sensory symptoms tend to dominate early in disease, with motor symptoms occuring later. The possibility of MAG antibody involvement in a suspected neuropathy may essentually be ruled out if a MAG IgM negative result is obtained. A recent publication suggests (Jaskowski et al. 2008) that detection of MAG IgM antibody by ELISA based on human MAG (100 kD) antigen is significantly more sensitive and specific than MAG Western blot and IFA assays using primate antigen.
Quantitation of anti-MAG antibody titers is an important aspect: on the one hand very low titers (otherwise negative in Western Blots) may be suggestive for a different neuropathy. On the other hand, new therapy concepts based on monoclonal antibodies (e g Rituximab) need a follow-up on anti-MAG antibody titers.

Your advantages with the the anti-MAG ELISA from BÜHLMANN:

Accuracy: Precoated Microtiterplate convenience

Specificity: The use of highly purified human MAG results in best likelihood to detect all positive patients.
Using microtiterplate with extremely low unspecific binding properties
No blocking proteins thus reducing the chance for false positive samples.
Reproducibility: Premeasured standards and two controls ensure low interassay variation.

Standardization: Standard curve with standardized titer units -

Quantitation: Allowing therapy monitoring of therapeutic intervention (e.g. Rituximab)

Product Information

Anti-MAG

Method

ELISA

Time to results

5 h

Sample Type

2 µl serum (1:1000)

Standard range

1000 - 70000 BTU

Cut-off

1000 BTU

Order code

EK-MAG 96 wells
CE

DOWNLOADS

Instruction
for use*

Clinical Information

Technical Information

English  

[PDF 0.3MB] [PDF 0.3MB] [PDF 0.3MB]

Deutsch

[PDF 0.3MB] [PDF 0.3MB]

Francais

[PDF 0.3MB] [PDF 0.3MB]

Italiano


[PDF 0.3MB]

* Multilingual document [EN, DE, FR, IT, ES]

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference

Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2  more

Measuring of Mineralwaters and Softdrinks on Arena and Aquakem

The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe  more

BÜHLMANN Calprotectin Test introduced in Belgium

The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro  more

Distribution of BioPorto’s NGAL ELISA

In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France .  more

Get our RSS - Feed